NDAORALTABLET, EXTENDED RELEASE
Approved
Dec 2009
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
2
Mechanism of Action
Adrenergic alpha2-Agonists
Pharmacologic Class:
Central alpha-2 Adrenergic Agonist
Clinical Trials (2)
Bioequivalence of Two Transdermal Clonidine Administrations in Healthy Volunteers
Started Mar 2014
56 enrolled
Healthy
Comparison of Keppra and Clonidine in the Treatment of Tics
Started Feb 2007
12 enrolled
Tic DisordersTourette Syndrome
Loss of Exclusivity
LOE Date
Sep 8, 2031
67 months away
Patent Expiry
Sep 8, 2031